Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer

Table 7

Per capita workloss days and costs during the 12-month study period.

	Employee subsample
	Cases		Controls		𝑃-value^a
	No.	%	No.	%
𝑁	78		78
Workloss rate^b
Medically  related  absenteeism	74	95%	76	97%	0.4142
Disability	27	35%	20	26%	0.2367
Workloss days	mean	(SD)	Mean	(SD)	𝑃-value^a
Medically  related  absenteeism	31.5	(28.1)	25.3	(18.2)	0.0573
Disability	37.4	(75.4)	20.4	(50.8)	0.1048
Workloss costs	mean	(SD)	mean	(SD)	𝑃-value^a
Total employer costs	$11,298	($11,830)	$9,043	($12,416)	0.2161
Medically  related  absenteeism	$6,329	($7,136)	$5,687	($6,200)	0.5012
Disability	$4,970	($10,994)	$3,356	($10,284)	0.3134

SD indicates standard deviation.
^a𝑃-values are determined using McNemar tests for proportions and paired 𝑡-tests for continuous measures.
^bWorkloss rate defined as the number of people with ≥1 disability claim or ≥1 instance of medically-related absenteeism.